SCHEMBL5773585

SCHEMBL5773585

O=C(O)CCCc1cnoc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
RXRA P19793 9/20 0.52
RXRB P28702 9/20 0.52
RXRG P48443 7/20 0.52
NR4A2 P43354 3/20 0.52
MAPK1 P28482 2/20 0.46
ADRA1A P35348 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC1 Q13547 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774472 0.91 RXRA (0.50) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5774948 0.88 FFAR1 (0.51) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5776248 0.83 TDO2 (0.45) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5770831 0.82 NR4A2 (0.52) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5773828 0.81 NR4A2 (0.47) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5773427 0.80 TDO2 (0.42) ALDH1A1RXRARXRBRXRGEPHX2
SCHEMBL5773847 0.78 CCNC (0.47) ALDH1A1NR4A2SMN1; SMN2PTGS1KDM4E
SCHEMBL5776861 0.78 PPARA (0.48) ALDH1A1RXRARXRBRXRGNR4A2
SCHEMBL5772923 0.78 TSHR (0.55) ALDH1A1RXRARXRBRXRGKDM4E
SCHEMBL5772507 0.78 RXRA (0.50) ALDH1A1RXRARXRBRXRGNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885RXRA 445/4885RXRB 494/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885RXRA 462/4885RXRB 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.